Existing investors Novartis Venture Fund and Partners Innovation Fund chipped in as the hearing loss therapy developer closed its latest round.

Aflac Ventures has invested in cardiac diagnosis system developer Tricog Health as part of a $10.5m round that took its total funding to more than $17m.

Eli Lilly and WuXi AppTec contributed to what was reportedly a down round for T-cell oncology treatment developer Immunocore following a $320m raise in 2015.

Eli Lilly and WuXi AppTec contributed to what was reportedly a down round for T-cell oncology treatment developer Immunocore following a $320m raise in 2015.

University of Tokyo Edge Capital has returned to invest in AI-assisted cardiac diagnosis technology developer Tricog Health.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The immuno-oncology therapy developer has raised a sliver over $100m, Takeda Ventures leading a round that included M Ventures, Ipsen Ventures and MRL Ventures Fund.

The university has put together a $1m fund for health-oriented participants in its Velocity accelerator competition.

The Comcast, McKesson, Humana and Independence Health-backed digital health concierge developer has set an initial target of $100m for its proposed flotation.

Anthem and existing investor Comcast Ventures took part in a round that reportedly boosted medical advice app developer K Health's overall funding to about $97m.